Pharmacokinetic Profile Route of Administration Oral Half-Life 6-8 hours Route of Administration: Oral, Intravenous Dosing Frequency: Once per day Half-Life: ~6-8 hours Formulation & Handling Soluble in saline
BPC-157 offers indirect advantages for muscle development by enhancing recovery capacity and tissue resilience
Repeated freeze-thaw cycles should be strictly limited to no more than three, as each cycle promotes peptide bond hydrolysis and aggregation that progressively reduces recoverable bioactive peptide content
BPC-157 has been studied extensively in preclinical models and has demonstrated meaningful effects on tissue repair, tendon and ligament healing, muscle recovery, wound healing, angiogenesis, nitric oxide signaling, inflammation modulation, and gastrointestinal mucosal protection
Klicek R, Kolenc D, Suran J, et al